P. Trouiller

Drug development output: what proportion for tropical diseases?

P. Olliaro, P. Trouiller, 1999, The Lancet.

Drug development for neglected diseases: a deficient market and a public-health policy failure

Els Torreele, James Orbinski, N. Ford, 2002, The Lancet.

Drugs for neglected diseases: a failure of the market and a public health failure?

D. Wirth, P. Olliaro, S. Foster, 2001, Tropical medicine & international health : TM & IH.

[Pharmaceutical development concerning diseases predominating in tropical regions: the concept of indigent drugs].

J. Rey, P. Trouiller, P. Bouscharain, 2000, Annales Pharmaceutiques Françaises.

Access to essential drugs in poor countries: a lost battle?

B. Pécoul, J. Pinel, P. Chirac, 1999, JAMA.

The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment.

Belen Pedrique, Jean-Hervé Bradol, N. Ford, 2013, The Lancet. Global health.

Drug development output from 1975 to 1996: what proportion for tropical diseases?

P. Olliaro, P L Olliaro, P Trouiller, 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts

C. Battistella, B. Pécoul, J. Pinel, 1999, Tropical medicine & international health : TM & IH.

[Generic drugs in developing countries].

P. Trouiller, 1996, Sante.